Literature DB >> 33926766

2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Steve R Ommen, Seema Mital, Michael A Burke, Sharlene M Day, Anita Deswal, Perry Elliott, Lauren L Evanovich, Judy Hung, José A Joglar, Paul Kantor, Carey Kimmelstiel, Michelle Kittleson, Mark S Link, Martin S Maron, Matthew W Martinez, Christina Y Miyake, Hartzell V Schaff, Christopher Semsarian, Paul Sorajja, Patrick T O'Gara, Joshua A Beckman, Glenn N Levine, Sana M Al-Khatib, Anastasia Armbruster, Kim K Birtcher, Joaquin Ciggaroa, Dave L Dixon, Lisa de Las Fuentes, Anita Deswal, Lee A Fleisher, Federico Gentile, Zachary D Goldberger, Bulent Gorenek, Norrisa Haynes, Adrian F Hernandez, Mark A Hlatky, José A Joglar, W Schuyler Jones, Joseph E Marine, Daniel Mark, Latha Palaniappan, Mariann R Piano, Jacqueline Tamis-Holland, Duminda N Wijeysundera, Y Joseph Woo.   

Abstract

Entities:  

Keywords:  ACC/AHA Clinical Practice Guidelines; atrial fibrillation; cardiovascular magnetic resonance; diastolic dysfunction; echocardiography; exercise stress testing; family screening; genetics; guidelines; hypertrophic cardiomyopathy; implantable cardioverter defibrillator; left ventricular outflow tract obstruction; occupation; physical activity; pregnancy; rhythm monitoring; risk stratification; sarcomeric genes; septal alcohol ablation; septal reduction therapy; shared decision-making; sudden cardiac death; surgical myectomy; systolic dysfunction; ventricular arrhythmias

Mesh:

Year:  2021        PMID: 33926766     DOI: 10.1016/j.jtcvs.2021.04.001

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  6 in total

Review 1.  A Comprehensive Assessment of Cardiomyopathies through Cardiovascular Magnetic Resonance: Focus on the Pediatric Population.

Authors:  Francesca Baessato; Cristina Romeo; Mark G Rabbat; Gianluca Pontone; Christian Meierhofer
Journal:  Diagnostics (Basel)       Date:  2022-04-19

2.  Genetic Clues on Implantable Cardioverter-Defibrillator Placement in Young-Age Hypertrophic Cardiomyopathy: A Case Report of Novel MYH7 Mutation and Literature Review.

Authors:  Xing Li; Jie Tang; Jinhui Li; Sha Lin; Tao Wang; Kaiyu Zhou; Yifei Li; Yimin Hua
Journal:  Front Cardiovasc Med       Date:  2021-12-23

3.  Negative inotropic mechanisms of β-cardiotoxin in cardiomyocytes by depression of myofilament ATPase activity without activation of the classical β-adrenergic pathway.

Authors:  Tuchakorn Lertwanakarn; Montamas Suntravat; Elda E Sánchez; Beata M Wolska; R John Solaro; Pieter P de Tombe; Kittipong Tachampa
Journal:  Sci Rep       Date:  2021-10-27       Impact factor: 4.379

4.  The Establishment of Hypertrophic Cardiomyopathy Diagnosis Model via Artificial Neural Network and Random Decision Forest Method.

Authors:  Shuanglei Li; Zekun Feng; Cangsong Xiao; Yang Wu; Weihua Ye
Journal:  Mediators Inflamm       Date:  2022-09-15       Impact factor: 4.529

5.  A Bioinformatic Approach Based on Systems Biology to Determine the Effects of SARS-CoV-2 Infection in Patients with Hypertrophic Cardiomyopathy.

Authors:  Xiao Han; Fei Wang; Ping Yang; Bin Di; Xiangdong Xu; Chunya Zhang; Man Yao; Yaping Sun; Yangyi Lin
Journal:  Comput Math Methods Med       Date:  2022-09-27       Impact factor: 2.809

6.  Treatment of Severe Left Ventricular Outflow Tract Obstruction and Mitral Regurgitation With Alcohol Septal Ablation.

Authors:  Michael Morcos; Aaron Strobel; John Messenger; Edward Gill
Journal:  CASE (Phila)       Date:  2022-08-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.